scholarly article | Q13442814 |
P2093 | author name string | Shruti Goel | |
Harini Ravi | |||
Brynn Levy | |||
Allison Ryan | |||
Zachary P Demko | |||
Nathan Hunkapiller | |||
Gabriel McNeill | |||
Steven D Meltzer | |||
P2860 | cites work | Presence of fetal DNA in maternal plasma and serum | Q57075132 |
Cell-free fetal DNA in maternal circulation after amniocentesis | Q73552686 | ||
The fate of children with microdeletion 22q11.2 syndrome and congenital heart defect: clinical course and cardiac outcome | Q81376555 | ||
Cell-free DNA testing for 22q11.2 deletion syndrome: appraising the viability, effectiveness and appropriateness of screening | Q87205083 | ||
Practical guidelines for managing patients with 22q11.2 deletion syndrome | Q28237543 | ||
Prevalence of recurrent pathogenic microdeletions and microduplications in over 9500 pregnancies | Q28261842 | ||
Expanding the scope of noninvasive prenatal testing: detection of fetal microdeletion syndromes | Q34452242 | ||
Prevalence of hypocalcaemia and its associated features in 22q11·2 deletion syndrome | Q34507393 | ||
Neonatal hypocalcemia, neonatal seizures, and intellectual disability in 22q11.2 deletion syndrome | Q35695641 | ||
Targeted capture enrichment assay for non-invasive prenatal testing of large and small size sub-chromosomal deletions and duplications | Q36269719 | ||
Chromosomal microarray versus karyotyping for prenatal diagnosis | Q36546668 | ||
22q11.2 deletion syndrome | Q36988231 | ||
Clinical outcome of subchromosomal events detected by whole-genome noninvasive prenatal testing | Q37279297 | ||
Clinical experience with single-nucleotide polymorphism-based non-invasive prenatal screening for 22q11.2 deletion syndrome | Q37340281 | ||
Clinical validation of a noninvasive prenatal test for genomewide detection of fetal copy number variants | Q39980269 | ||
The effect of chorionic villus sampling on the fraction of cell-free fetal DNA in maternal plasma | Q41202120 | ||
The annual incidence of DiGeorge/velocardiofacial syndrome | Q41871255 | ||
Clinical experience with a single-nucleotide polymorphism-based non-invasive prenatal test for five clinically significant microdeletions | Q46081566 | ||
Prenatal Screening for 22q11.2 Deletion Using a Targeted Microarray-Based Cell-Free DNA Test. | Q46480890 | ||
Confined placental mosaicism for 22q11.2 deletion as the etiology for discordant positive NIPT results | Q48235938 | ||
Noninvasive prenatal testing: the paradigm is shifting rapidly | Q48240788 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | e0193476 | |
P577 | publication date | 2018-02-23 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Validation of a SNP-based non-invasive prenatal test to detect the fetal 22q11.2 deletion in maternal plasma samples. | |
P478 | volume | 13 |
Q102061414 | High-throughput fetal fraction amplification increases analytical performance of noninvasive prenatal screening |
Q64232954 | Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions: A Health Technology Assessment |
Q92905974 | Quality Assurance of Non-Invasive Prenatal Screening (NIPS) for Fetal Aneuploidy Using Positive Predictive Values as Outcome Measures |
Q89966092 | The Genetics and Epigenetics of 22q11.2 Deletion Syndrome |
Search more.